Related Experiment Video
Updated: Sep 26, 2026

Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner
Published on: June 7, 2024
Octreoscan radioreceptor imaging
Aart J van der Lely1, Wouter W de Herder, Eric P Krenning
1Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands. vanderlely@inw3.azr.nl
Abstract:
With the in vivo demonstration of somatostatin-receptor- positive tumors in patients using a radiolabeled somatostatin analog, peptide receptor scintigraphy became available some 15 yr ago. Octreoscan is a radiopharmaceutical with proven clinical importance in the visualization of somatostatin-receptor-positive tumors, and the overall sensitivity of somatostatin receptor imaging is high. In a number of neuroendocrine tumor types, as well as in Hodgkin's disease, inclusion of somatostatin receptor imaging in the localization or staging procedure may be very rewarding. The value of somatostatin receptor imaging in patients with other tumors, like breast cancer, or in patients with granulomatous diseases, has to be established.
Insights
Peptide receptor scintigraphy, using Octreoscan, effectively visualizes somatostatin-receptor-positive tumors. This imaging technique is valuable for staging neuroendocrine tumors and Hodgkin
Area of Science:
- Nuclear Medicine
- Oncology
- Radiopharmacology
Background:
- Peptide receptor scintigraphy emerged 15 years ago for in vivo tumor visualization.
- Octreoscan is a key radiopharmaceutical for imaging somatostatin-receptor-positive tumors.
- Somatostatin receptor imaging demonstrates high overall sensitivity.
Purpose of the Study:
- To evaluate the clinical utility of somatostatin receptor imaging.
- To highlight the role of Octreoscan in tumor localization and staging.
Main Methods:
- In vivo demonstration of somatostatin-receptor-positive tumors.
- Utilizing radiolabeled somatostatin analogs.
- Application of peptide receptor scintigraphy.
Main Results:
- Octreoscan is clinically important for visualizing somatostatin-receptor-positive tumors.
- Somatostatin receptor imaging is highly sensitive.
- Imaging is beneficial for staging neuroendocrine tumors and Hodgkin's disease.
Conclusions:
- Somatostatin receptor imaging, particularly with Octreoscan, is a valuable tool for specific tumor types.
- Further studies are needed to establish its role in breast cancer and granulomatous diseases.
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
X-ray Imaging
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)